Chinese ADC Developers Catch Up with Global Players In Advancing Key Payloads
Multiple Active Players
Chinese pharma firms led by Kelun are moving fast to develop the next-generation of cytotoxic "warheads," a key component of antibody-drug conjugates, disclosed company executives at conference in Suzhou.
